Kewaunee Scientific (KEQU) EBITDA (2010 - 2026)

Kewaunee Scientific's EBITDA history runs 17 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• In Q1 2026, EBITDA rose 14.76% year-over-year to $2.6 million; the TTM figure through Jan 2026 stood at $20.0 million (up 34.97% YoY), while the FY2025 annual figure was $17.8 million, down 2.86% from the prior year.
• EBITDA was $2.6 million for Q1 2026 at Kewaunee Scientific, down from $4.1 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $8.5 million in Q2 2025 to a low of -$868000.0 in Q1 2022.
• Historically, EBITDA has averaged $3.2 million across 5 years, with a median of $2.7 million in 2023.
• The sharpest annual moves came in 2022 and 2023: EBITDA slumped 130.85% in 2022, then soared 1061.62% in 2023.
• A 5-year view of EBITDA shows it stood at $755000.0 in 2022, then soared by 576.69% to $5.1 million in 2023, then dropped by 13.21% to $4.4 million in 2024, then retreated by 7.37% to $4.1 million in 2025, then sank by 37.13% to $2.6 million in 2026.
• The last three EBITDA figures came in at $2.6 million (Q1 2026), $4.1 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.